Vivid Seats director granted 19,488 RSUs

DeFlorio Jane E. reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

DeFlorio Jane E. reported acquisition or exercise transactions in this Form 4 filing.

Vivid Seats Inc. director Jane E. DeFlorio reported receiving a grant of 19,488 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Class A common stock. The RSUs vest in full on the earlier of June 9, 2027 or one day before the 2027 Annual Meeting of Stockholders and do not have an expiration date.

Insider Trade Summary

Grant/Award: 19,488 shares

Grant/Award 1 txn

Insider DeFlorio Jane E.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	19,488	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 19,488 contracts (Direct)

Footnotes (2)

F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2. The RSUs vest in full on the earlier of (i) June 9, 2027 and (ii) one day prior to the Company's 2027 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

Key Figures

RSUs granted: 19,488 units Underlying shares: 19,488 shares Exercise price: $0.00 per unit +1 more

4 metrics

RSUs granted 19,488 units Equity award to director Jane E. DeFlorio

Underlying shares 19,488 shares Class A common stock underlying granted RSUs

Exercise price $0.00 per unit RSU grant has no purchase price

Vesting date trigger June 9, 2027 Earlier of this date or one day prior to 2027 annual meeting

Key Terms

Restricted Stock Units, Class A common stock, Annual Meeting of Stockholders, vest in full

4 terms

Restricted Stock Units financial

"Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A common stock financial

"to receive one share of Class A common stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Annual Meeting of Stockholders regulatory

"one day prior to the Company's 2027 Annual Meeting of Stockholders"

vest in full financial

"The RSUs vest in full on the earlier of (i) June 9, 2027"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vivid Seats (SEAT) director Jane E. DeFlorio report in this Form 4?

Director Jane E. DeFlorio reported receiving 19,488 Restricted Stock Units as an equity award. These RSUs are a form of stock-based compensation that can convert into shares of Vivid Seats Class A common stock once vesting conditions are satisfied.

How many Restricted Stock Units were granted to the Vivid Seats (SEAT) director?

Jane E. DeFlorio was granted 19,488 Restricted Stock Units. Each unit represents a contingent right to receive one share of Vivid Seats Class A common stock, providing the director with potential future ownership if vesting requirements are met.

When do the RSUs granted to the Vivid Seats (SEAT) director vest?

The RSUs vest in full on the earlier of June 9, 2027, or one day before Vivid Seats’ 2027 Annual Meeting of Stockholders. Full vesting at that time means all 19,488 units can become shares, subject to any applicable company or tax requirements.

What does each RSU represent in the Vivid Seats (SEAT) Form 4 filing?

Each Restricted Stock Unit represents a contingent right to receive one share of Vivid Seats Class A common stock. The units themselves are not shares until they vest and settle, aligning director compensation with future company performance and stock value.

Do the Vivid Seats (SEAT) RSUs reported by the director have an expiration date?

The RSUs do not have an expiration date. Instead, they vest in full on a specific future date tied to June 9, 2027 or the 2027 Annual Meeting timing, after which they may be settled in shares of Class A common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/11/2026 - 04:15 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeFlorio Jane E.

(Last)

(First)

(Middle)

C/O VIVID SEATS INC.

24 E. WASHINGTON ST., STE. 900

(Street)

CHICAGO

ILLINOIS

60602

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivid Seats Inc. [ SEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	06/09/2026		A		19,488		⁽²⁾	⁽²⁾	Class A Common Stock	19,488	$0	19,488	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. The RSUs vest in full on the earlier of (i) June 9, 2027 and (ii) one day prior to the Company's 2027 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

	/s/ Lawrence Fey, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR